Perspective on combination RAS blocking therapy: off-TARGET, dis-CORD, MAP-to-nowhere, low ALTITUDE, and NEPHRON-D

Am J Nephrol. 2014;39(1):46-9. doi: 10.1159/000357593. Epub 2014 Jan 15.

Author

Friedrich C Luft¹

Affiliation

¹ Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Medical Faculty of the Charité, Berlin, Germany.

PMID: 24434833
DOI: 10.1159/000357593

No abstract available

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Antihypertensive Agents / administration & dosage
Blood Pressure
Clinical Trials as Topic
Diabetes Complications / drug therapy
Diabetes Mellitus, Type 2 / physiopathology*
Humans
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / drug therapy*
Renin-Angiotensin System / drug effects
Research Design
Treatment Outcome

Substances

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents